Bovine-based Collagen for Biomedical Applications Market, By Type (Bone Graft Substitutes, Cartilage Repairs, Collagen-based Scaffolds, Hemostats, Skin Substitutes, and Wound Dressings), By Application and By Region- Trends, Analysis and Forecast till 2034

Report Code: PMI291619 | Publish Date: February 2024 | No. of Pages: 182

Global Bovinebased Collagen For Biomedical Overview

Bovine-based Collagen for Biomedical Applications Market was valued at USD 893.7 Million in 2024 and is projected to grow at a CAGR of 10.7% to reach USD 2477 Million by 2034

Collagen, most abundant protein in human body and found in animals serves as building blocks in skin, bones, tendons, blood vessels. Collagen is also widespread as supplement and food additive. Bovine collagen is derived from cows. After extraction, it is dried and powdered to form a supplement.

Global Bovinebased Collagen For Biomedical Drivers & Restraints

Regional Insights:

On region the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

  • North America market is estimated to witness a significantly high revenue share over the forecast period due to increase investment, developed healthcare infrastructure, presence of strong pharmaceutical companies.
  • Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to improving healthcare infrastructure, entry of new players

Global Bovinebased Collagen For Biomedical Segmentations & Regional Insights

Dividing this target market into segments:

Bovine-based Collagen for Biomedical Applications Market is segmented based on Type, Application and Region.

Type Insight

On the basis of Type, the target market is segmented into Bone Graft Substitutes, Cartilage Repairs, Collagen-based Scaffolds, Hemostats, Skin Substitutes, and Wound Dressings

Application Insight

On the basis of Application, the target market is segmented into Hospitals and Ambulatory Surgical Centers

Report Scope:

Attribute

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Type – Bone Graft Substitutes, Cartilage Repairs, Collagen-based Scaffolds, Hemostats, Skin Substitutes, and Wound Dressings

By Application - Hospitals and Ambulatory Surgical Centers

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034.

Few Other Promising Reports:

Global Bovinebased Collagen For Biomedical Competitive Landscape & Key Players

The key players operating the Bovine-based Collagen for Biomedical Applications Market includes, BBI Solutions, Ltd., Symatese Group, Gurnet Point Capital, Viscofan BioEngineering, Collagen Solutions LLP, Botiss biomaterials GmbH, Medtronic, Inc., Taxus Cardium, KYERON Medical Innovations, Collagen Matrix, Inc.

Global Bovinebased Collagen For Biomedical Recent News

The New Launched Product News,

  • In June 2023, US-based biotech company Jellatech announced a huge milestone with the development of cultivated collagen made from the company’s own proprietary cell lines. They utilized animal cells for collagen production and obtained a bio-identical collagen product, naturally found only in animals.

Global Bovinebased Collagen For Biomedical Company Profile

  • BBI Solutions, Ltd
  • Symatese Group
  • Gurnet Point Capital
  • Viscofan BioEngineering
  • Collagen Solutions LLP
  • Botiss biomaterials GmbH
  • Medtronic, Inc.
  • Taxus Cardium
  • KYERON Medical Innovations
  • Collagen Matrix, Inc.

FAQs

Bovine-based Collagen for Biomedical Applications Market was valued at US$ 893.7 million in 2024 and is projected to grow at a CAGR of 10.7% to reach US$ 2477 million by 2034.

The Global Bovine-based Collagen for Biomedical Applications Market is projected to increase at a CAGR 10.7% during the forecast period.

The global bovine-based collagen for biomedical applications market report segments the market on the basis of type, application, and region.